Updates
Jubilant Life Sciences Ltd has informed BSE that consequent to appointment of Mr. Shyam S. Bhartia as Chairman and Managing Director of Jubilant Pharma Limited, Singapore, a wholly-owned subsidiary of Jubilant Life Sciences Limited (the Company), he has resigned from the position of Managing Director of the Company effective from March 25, 2015. In view of the above, Mr. Shyam S. Bhartia shall be Non-executive Chairman and Director of the Company. Jubilant Life Sciences receives ANDA approval for Montelukast
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated March 02, 2015, titled "Jubilant Life Sciences receives ANDA approval for Montelukast". Notice of Postal Ballot
Jubilant Life Sciences Ltd has informed BSE that the members of the Company will consider to approve the special resolution, by way of Postal Ballot. Jubilant Life Sciences receives ANDA approvals for Irbesartan and Cetirizine
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated February 24, 2015, titled "Jubilant Life Sciences receives ANDA approvals for Irbesartan and Cetirizine". Appointment of Company Secretary & Compliance Officer
Jubilant Life Sciences Ltd has informed BSE that Mr. Rajiv Shah has been appointed as Company Secretary of the Company with effect from February 16, 2015. He shall also be the Compliance officer of the Company. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Cessation of Company Secretary
Jubilant Life Sciences Ltd has informed BSE that Mr. Lalit Jain has retired from the services of the Company w.e.f. close of working hours of January 31, 2015.Accordingly, Mr. Lalit Jain is ceased to be the Company Secretary of the Company w.e.f. close of working hours of January 31, 2015. Announces Q3 Results, Results Press Release, Investors Presentation & Limited Review Report for Dec 31, 2014
Jubilant Life Sciences Ltd has announced the following results for the quarter ended December 31, 2014:The Un-Audited Standalone results for the Quarter ended December 31, 2014The Company has posted a net (loss) of Rs. (84.80) million for the quarter ended December 31, 2014 as compared to Net Profit of Rs. 1645.20 million for the quarter ended December 31, 2013. Total Income has decreased from Rs. 9574.10 million for the quarter ended... Q3 results on Feb 03, 2015
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 03, 2015, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2014 (Q3).Further, as per the Company's Insider Trading Code, the Trading Window for dealing in the securities of the Company would remain closed for all Directors/Officers/Designated Employees... Shareholding Pattern For December 31, 2014
Jubilant Life Sciences Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.